Variant report
Variant | nsv963976 |
---|---|
Chromosome Location | chr2:57596217-57602238 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:57602104..57602641-chr2:57724502..57725135,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138252355 | chr2:57596226-57596227 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149616543 | chr2:57596324-57596325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553015869 | chr2:57596338-57596339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188623108 | chr2:57596359-57596360 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72935541 | chr2:57596367-57596368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143368669 | chr2:57596375-57596376 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139343174 | chr2:57596376-57596377 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs192997125 | chr2:57596405-57596406 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534124139 | chr2:57596432-57596433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185603096 | chr2:57596441-57596442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374948569 | chr2:57596454-57596455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188035693 | chr2:57596474-57596475 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs55658488 | chr2:57596585-57596586 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs10199165 | chr2:57596612-57596613 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs562572223 | chr2:57596650-57596651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs540429261 | chr2:57596670-57596671 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs576082037 | chr2:57596689-57596690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs7570448 | chr2:57596690-57596691 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs369531459 | chr2:57596727-57596728 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192562933 | chr2:57596736-57596737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533441112 | chr2:57596790-57596791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546841688 | chr2:57596794-57596795 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs143354039 | chr2:57596814-57596815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13406256 | chr2:57596841-57596842 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs12478981 | chr2:57596861-57596862 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs569312883 | chr2:57596904-57596905 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531750533 | chr2:57596924-57596925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531785059 | chr2:57596936-57596937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs78209183 | chr2:57596951-57596952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs17048787 | chr2:57596962-57596963 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs534192492 | chr2:57597034-57597035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554072665 | chr2:57597056-57597057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567585483 | chr2:57597069-57597070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568757022 | chr2:57597091-57597092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536426962 | chr2:57597092-57597093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556119094 | chr2:57597116-57597117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537886664 | chr2:57597155-57597156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs576078348 | chr2:57597167-57597168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139897164 | chr2:57597173-57597174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61321208 | chr2:57597221-57597222 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs571667559 | chr2:57597277-57597278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540643367 | chr2:57597359-57597360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs560386103 | chr2:57597365-57597366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72935546 | chr2:57597382-57597383 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs546499807 | chr2:57597430-57597431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543193072 | chr2:57597461-57597462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562983139 | chr2:57597463-57597464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs531831405 | chr2:57597468-57597469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs202099685 | chr2:57597493-57597494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs57228556 | chr2:57597494-57597495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:57593600-57601000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr2:57595800-57599600 | Weak transcription | NHEK | skin |
3 | chr2:57595800-57600000 | Weak transcription | HMEC | breast |
4 | chr2:57596200-57596800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr2:57598000-57598400 | Enhancers | HSMMtube | muscle |
6 | chr2:57598200-57598400 | Enhancers | HSMM | muscle |
7 | chr2:57598400-57599800 | Weak transcription | HSMMtube | muscle |
8 | chr2:57598400-57602000 | Enhancers | Muscle Satellite Cultured Cells | -- |
9 | chr2:57598600-57599600 | Weak transcription | HSMM | muscle |
10 | chr2:57599000-57601400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
11 | chr2:57599400-57601400 | Enhancers | HUVEC | blood vessel |
12 | chr2:57599600-57600200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr2:57599600-57601400 | Enhancers | NHEK | skin |
14 | chr2:57599600-57601800 | Enhancers | HSMM | muscle |
15 | chr2:57599600-57601800 | Enhancers | NHDF-Ad | bronchial |
16 | chr2:57599800-57600000 | Active TSS | A549 | lung |
17 | chr2:57599800-57601400 | Enhancers | HSMMtube | muscle |
18 | chr2:57600000-57600200 | Flanking Active TSS | A549 | lung |
19 | chr2:57600000-57601000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr2:57600000-57601200 | Enhancers | NH-A | brain |
21 | chr2:57600000-57601400 | Enhancers | HMEC | breast |
22 | chr2:57600200-57601800 | Enhancers | A549 | lung |
23 | chr2:57601000-57601200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |